Enovis EBITDA Margin 2010-2023 | ENOV
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Enovis (ENOV) over the last 10 years. The current EBITDA margin for Enovis as of December 31, 2023 is .
| Enovis EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-12-31 | $1.71B | $0.15B | 8.90% |
| 2023-09-30 | $1.66B | $0.13B | 7.52% |
| 2023-06-30 | $1.63B | $0.12B | 7.49% |
| 2023-03-31 | $1.59B | $0.14B | 8.78% |
| 2022-12-31 | $1.56B | $0.15B | 9.47% |
| 2022-09-30 | $0.99B | $0.09B | 9.34% |
| 2022-06-30 | $0.96B | $0.11B | 11.76% |
| 2022-03-31 | $0.92B | $0.11B | 12.15% |
| 2021-12-31 | $1.43B | $0.20B | 14.10% |
| 2021-09-30 | $0.47B | $0.13B | 27.06% |
| 2021-06-30 | $0.92B | $0.20B | 21.55% |
| 2021-03-31 | $1.18B | $0.20B | 16.82% |
| 2020-12-31 | $1.12B | $0.18B | 16.07% |
| 2020-09-30 | $3.13B | $0.42B | 13.48% |
| 2020-06-30 | $3.17B | $0.44B | 13.78% |
| 2020-03-31 | $3.46B | $0.50B | 14.36% |
| 2019-12-31 | $3.33B | $0.44B | 13.19% |
| 2019-09-30 | $2.67B | $0.35B | 13.09% |
| 2019-06-30 | $2.34B | $0.29B | 12.16% |
| 2019-03-31 | $2.00B | $0.25B | 12.42% |
| 2018-12-31 | $2.19B | $0.30B | 13.68% |
| 2018-09-30 | $1.48B | $0.40B | 26.95% |
| 2018-06-30 | $1.80B | $0.43B | 24.03% |
| 2018-03-31 | $2.09B | $0.46B | 22.01% |
| 2017-12-31 | $1.94B | $0.45B | 23.32% |
| 2017-09-30 | $3.01B | $0.40B | 13.28% |
| 2017-06-30 | $2.93B | $0.38B | 13.09% |
| 2017-03-31 | $3.04B | $0.39B | 12.68% |
| 2016-12-31 | $3.19B | $0.38B | 11.93% |
| 2016-09-30 | $3.13B | $0.38B | 12.04% |
| 2016-06-30 | $3.33B | $0.37B | 11.10% |
| 2016-03-31 | $3.40B | $0.39B | 11.53% |
| 2015-12-31 | $3.43B | $0.42B | 12.23% |
| 2015-09-30 | $4.11B | $0.48B | 11.75% |
| 2015-06-30 | $4.31B | $0.56B | 13.01% |
| 2015-03-31 | $4.48B | $0.58B | 12.95% |
| 2014-12-31 | $4.62B | $0.59B | 12.65% |
| 2014-09-30 | $4.59B | $0.58B | 12.73% |
| 2014-06-30 | $4.44B | $0.56B | 12.53% |
| 2014-03-31 | $4.31B | $0.54B | 12.56% |
| 2013-12-31 | $4.21B | $0.53B | 12.48% |
| 2013-09-30 | $4.06B | $0.46B | 11.25% |
| 2013-06-30 | $4.00B | $0.42B | 10.52% |
| 2013-03-31 | $3.97B | $0.39B | 9.76% |
| 2012-12-31 | $3.91B | $0.32B | 8.28% |
| 2012-09-30 | $3.06B | $0.24B | 7.73% |
| 2012-06-30 | $2.28B | $0.15B | 6.58% |
| 2012-03-31 | $1.42B | $0.07B | 4.93% |
| 2011-12-31 | $0.69B | $0.05B | 7.06% |
| 2011-09-30 | $0.68B | $0.08B | 11.27% |
| 2011-06-30 | $0.65B | $0.08B | 12.25% |
| 2011-03-31 | $0.58B | $0.06B | 11.02% |
| 2010-12-31 | $0.54B | $0.05B | 9.59% |
| 2010-09-30 | $0.51B | $0.04B | 8.10% |
| 2010-06-30 | $0.50B | $0.04B | 8.35% |
| 2010-03-31 | $0.51B | $0.05B | 8.84% |
| 2009-12-31 | $0.53B | $0.06B | 10.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.030B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
| Inspire Medical Systems (INSP) | United States | $7.194B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.483B | 0.00 |
| Axonics (AXNX) | United States | $3.401B | 0.00 |
| 10x Genomics (TXG) | United States | $3.288B | 0.00 |
| Azenta (AZTA) | United States | $2.910B | 237.18 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.840B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.678B | 0.00 |
| Privia Health (PRVA) | United States | $2.167B | 96.11 |
| Schrodinger (SDGR) | United States | $1.733B | 0.00 |
| Omnicell (OMCL) | United States | $1.279B | 31.30 |
| Phreesia (PHR) | United States | $1.162B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.823B | 0.00 |
| Standard BioTools (LAB) | United States | $0.708B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.353B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.337B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.328B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.153B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.141B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.141B | 0.00 |
| Augmedix (AUGX) | United States | $0.139B | 0.00 |
| Outset Medical (OM) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.118B | 5.03 |
| 111 (YI) | China | $0.086B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.048B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |